<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00973687</url>
  </required_header>
  <id_info>
    <org_study_id>2967</org_study_id>
    <nct_id>NCT00973687</nct_id>
  </id_info>
  <brief_title>Dexamethasone Tolerability in the Treatment of Acute Asthma in Children</brief_title>
  <official_title>Dexamethasone Tolerability in the Treatment of Acute Asthma in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IWK Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IWK Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IWK Health Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether smaller volumes of oral dexamethasone result
      in better tolerability, specifically less vomiting, in pediatric patients during an acute
      asthma exacerbation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2004</start_date>
  <completion_date type="Actual">May 2006</completion_date>
  <primary_completion_date type="Actual">April 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective of this study was to assess whether smaller volumes of oral dexamethasone resulted in better tolerability, specifically less vomiting, in pediatric patients with an acute exacerbation of asthma.</measure>
    <time_frame>During Emergency Department visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate asthma symptom control post emergency room visit for acute asthma exacerbation.</measure>
    <time_frame>7-14 days following emergency dept visit</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">430</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>10 mg/mL Unsweetened Formulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no prior vomiting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 mg/mL Ora Sweet Formulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>no prior vomiting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 mg/mL Unsweetened with prior vomiting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>with prior vomiting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 mg/mL Ora Sweet with prior vomiting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>with prior vomiting</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ora Sweet</intervention_name>
    <description>A pharmaceutical suspending vehicle and flavouring agent added to the dexamethasone. All arms received the same amount of dexamethasone based on the child's weight, only in different volumes.</description>
    <arm_group_label>1 mg/mL Ora Sweet Formulation</arm_group_label>
    <arm_group_label>1 mg/mL Ora Sweet with prior vomiting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <arm_group_label>10 mg/mL Unsweetened Formulation</arm_group_label>
    <arm_group_label>1 mg/mL Ora Sweet Formulation</arm_group_label>
    <arm_group_label>10 mg/mL Unsweetened with prior vomiting</arm_group_label>
    <arm_group_label>1 mg/mL Ora Sweet with prior vomiting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute asthma exacerbation

          -  requiring oral systemic corticosteroids for management

        Exclusion Criteria:

          -  preference for pills over liquid formulation

          -  history of Nissen fundoplication surgery

          -  needed immediate airway intervention

          -  require oral medications to be given via a G or J tube

          -  if patient care would be compromised

          -  enrolled in the study on a previous visit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lyn K Sonnenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IWK Health Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2009</study_first_submitted>
  <study_first_submitted_qc>September 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2009</study_first_posted>
  <last_update_submitted>August 25, 2015</last_update_submitted>
  <last_update_submitted_qc>August 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2015</last_update_posted>
  <responsible_party>
    <name_title>Dr. Lyn Sonnenberg</name_title>
    <organization>IWK Health Centre</organization>
  </responsible_party>
  <keyword>pediatric</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>management</keyword>
  <keyword>corticosteroids</keyword>
  <keyword>asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

